Treatment of A549 lung cancer cells with the COX-2 gene activators, PMA, IL1β and TNFα increased levels of COX-2 protein (Figure 1G), mRNA and promoter RNA (Figure 1H). This evidence concerns the gene IL1B and lung carcinoma.